Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael K Srienc

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Surgery|March 25, 2024
Carnitine palmitoyltransferase 1B mediates gemcitabine resistance in pancreatic cancerMichael K Srienc, Timothy R Donahue
JAMA Surgery|April 15, 2026
Immunotherapy for Gastroesophageal Adenocarcinoma-Durable Responses, Open QuestionsMichael K Srienc, Timothy R Donahue
Journal of the American College of Surgeons|March 13, 2026
Pancreatic Stump Closure: Evolving Evidence, Enduring QuestionsMichael K Srienc, Timothy R Donahue
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Surgery|March 25, 2024
Carnitine palmitoyltransferase 1B mediates gemcitabine resistance in pancreatic cancerMichael K Srienc, Timothy R Donahue
JAMA Surgery|April 15, 2026
Immunotherapy for Gastroesophageal Adenocarcinoma-Durable Responses, Open QuestionsMichael K Srienc, Timothy R Donahue
Journal of the American College of Surgeons|March 13, 2026
Pancreatic Stump Closure: Evolving Evidence, Enduring QuestionsMichael K Srienc, Timothy R Donahue
Pageof 1